Project Details
| Status | Active |
|---|---|
| Effective start/end date | 10/31/22 → … |
Docetaxel Chemotherapy and Pembrolizumab Plus Interleukin-12 Gene Therapy in Triple Negative Breast Cancer (INTEGRAL)
- Chang, Jenny C. (PI)
- Niravath, Polly A. (Key Personnel)
- Venta, Luz A. (Key Personnel)
Project: Clinical Trial